Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 7, Number 3—June 2001

Research

Molecular Epidemiology of Serogroup A Meningitis in Moscow, 1969 to 1997

Mark Achtman*Comments to Author , Arie van der Ende†, Peixuan Zhu*, Irina S. Koroleva‡, Barica Kusecek*, Giovanna Morelli*, Ilse G.A. Schuurman†, Norbert Brieske*, Kerstin Zurth*, Natalya N. Kostyukova§, and Alexander E. Platonov‡
Author affiliations: *Max-Planck Institut für Molekulare Genetik, Berlin, Germany; †Academic Medical Center, Amsterdam, the Netherlands; ‡Central Research Institute of Epidemiology, Moscow, Russia; §N.F. Gamaleya Institute of Epidemiology and Microbiology, Moscow, Russia

Main Article

Table 2

Serologic properties of serogroup A meningococci from Moscow

Subgroup Proportion (%) Serotype Serosubtype
III 34/38 (89) 21 P1.20,9
VI 6/39 (15) 21 P1.10
VI 12/39 (31) 4,21 P1.10
VI 17/39 (44) 4,21 P1.5,10
X 17/24 (71) 4,21 P1.10
X 6/24 (25) 21 P1.10

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO